Table 5.
Multivariate logistic regression analysis of risk factors for mortality in COVID-19
Variable | Odds ratio (95% CI) | P value |
---|---|---|
Age, groups, n (%) | ||
65–74 75–84 ≥ 85 |
1 1.400 (0.763–2.570) 6.054 (2.719–13.479) |
0.277 < 0.001 |
Sex | ||
Female Male |
1 0.832 (0.474–1.460) |
0.522 |
Malignancy | 1.222 (0.579–2.582) | 0.599 |
CHF | 1.212 (0.542–2.712) | 0.640 |
Chronic renal disease | 0.956 (0.408–2.243) | 0.918 |
Polypharmacy | 6.782 (3.082–14.927) | < 0.001 |
Dsypnea | 57.916 (23.439–143.104) | < 0.001 |
WBC, 10^3/μL | 1.089 (1.035–1.145) | 0.001 |
Lymphocyte, 10^3/μL | 0.599 (0.390–0.920) | 0.019 |
AST, IU/L | 1.008 (1.000–1.015) | 0.043 |
ALT, IU/L | 1.001 (0.998–1.004) | 0.650 |
Highest CRP, mg/L | 1.007 (1.004–1.011) | < 0.001 |
Highest LDH, IU/L | 1.001 (1.000–1.002) | 0.005 |
Highest creatinine, mg/L | 1.015 (0.932–1.104) | 0.737 |
Highest ferritin, ng/mL | 1.001 (1.001–1.001) | < 0.001 |
Highest fibrinogen, mg/dL | 1.000 (0.998–1.002) | 0.787 |
Thorax CT classification | ||
0 (negative) 1 (atypical) 2 (indeterminate) 3 (typical) |
1 7.880 (1.711–34.502) 6.610 (1.425–29.995) 9.633 (2.511–37.122) |
0.009 0.017 < 0.001 |
Anticoagulation | ||
0: (no) 1: (yes) |
1 0.336 (0.132–0.855) |
0.022 |
Significant P values are in bold